PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)

PNC Financial Services Group Inc. lowered its stake in Sanofi (NASDAQ:SNY) by 48.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 100,496 shares of the company’s stock after selling 93,285 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Sanofi were worth $4,998,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of SNY. Rise Advisors LLC lifted its position in shares of Sanofi by 98.4% in the fourth quarter. Rise Advisors LLC now owns 506 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Salem Investment Counselors Inc. bought a new stake in shares of Sanofi in the fourth quarter worth $27,000. Venturi Wealth Management LLC lifted its position in shares of Sanofi by 163.5% in the fourth quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock worth $27,000 after purchasing an additional 332 shares in the last quarter. Frazier Financial Advisors LLC bought a new stake in shares of Sanofi in the fourth quarter worth $28,000. Finally, McIlrath & Eck LLC lifted its position in shares of Sanofi by 143.3% in the fourth quarter. McIlrath & Eck LLC now owns 613 shares of the company’s stock worth $30,000 after purchasing an additional 361 shares in the last quarter. Institutional investors own 10.04% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $55.00.

Sanofi Stock Performance

NASDAQ SNY opened at $47.22 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. The firm’s fifty day moving average price is $48.32 and its two-hundred day moving average price is $48.49. Sanofi has a 1 year low of $42.63 and a 1 year high of $55.72. The firm has a market capitalization of $119.46 billion, a P/E ratio of 23.73, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The firm had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. As a group, research analysts anticipate that Sanofi will post 4.09 EPS for the current year.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Thursday, June 6th. Shareholders of record on Friday, May 10th were issued a $1.478 dividend. This is an increase from Sanofi’s previous annual dividend of $1.38. This represents a dividend yield of 2.98%. The ex-dividend date of this dividend was Thursday, May 9th. Sanofi’s payout ratio is currently 74.37%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.